CCL19 as a Chemokine Risk Factor for Posttreatment Lyme Disease Syndrome: a Prospective Clinical Cohort Study

Supplemental material

• Supplemental file 1 -

  Table S1. Sixty-four cytokines, chemokines, and inflammatory markers of relevance in other immune-mediated illnesses measured using the Bio-Plex bead array system.

  PDF, 26K